Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans

Journal of Endocrinological Investigation

Volumn 22, Issue 4, 1999, Pages 266-272

  Bisi, G ^b   Podio, V ^c   Valette, M R ^c   Broglio, F ^c   Bertuccio, G ^c   Del Rio, G ^c   Arvat, E ^c   Boghen, M F ^c   Deghenghi, R ^a   Muccioli, G ^c   Ong, H ^c   Ghigo, E ^c  

^a Ardana   (France)

^b MOLINETTE HOSPITAL   (Italy)

^c NONE

Author keywords

Cardiac output; Catecholamines; GH; GH secretagogues; Hemodynamics; Left ventricular function; Radionuclide imaging

Indexed keywords

ALDOSTERONE; CATECHOLAMINE; GROWTH HORMONE; HEXARELIN; HUMAN GROWTH HORMONE; HYDROCORTISONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; GROWTH HORMONE RELEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART PERFORMANCE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN CELL; INOTROPISM; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SCINTIANGIOGRAPHY; STATISTICAL ANALYSIS;

EID: 0032959957     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343555     Document Type: Article

References (38)

1. Saccà L., Cittadini A., Fazio S. Growth hormone and the heart. Endocr. Rev. 1994, 15: 555-573.
2. Dortath M.Y., Zapf J., Eppenberger-Eberhardt M., Froesch E.R., Eppenberger H.M. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle-actin of adult cardiomyocytes. Proc. Natl. Acad. Sci. 1994, 91: 1686-1690.
3. lsgaard J., Kujacic V., Jennische E., Holmang A., Sun X.Y., Hedner T., Hialmarson A., Bengtsson B.A. Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur. J. Clin. Invest. 1997, 27: 517-525.
4. Duerr R.L., Huang S., Miraliakbar H.R., Clark R., Chien K.R., Ross J. Insulin-like Growth Factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 1997, 95: 619-627.
5. Cittadini A., Stromer H., Katz S.E., Katz S.E., Clark R., Moses A.C., Morgan J.P., Douglas P.S. Differential cardiac effects of growth hormone and insulin-like growth factor I in the rat. A combined in vivo and in vitro evaluation. Circulation 1996, 93: 800-809.
6. Yang R., Bunting S., Gillett N., Clark R., Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995, 92: 262-267.
7. Shahi M., Beshyah S.A., Hackett D., Sharp P.S., Johnston D.G., Foale R.A. Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br. Heart J. 1992, 67: 92-96.
8. Amato G., Carella C., Fazio S., La Montagna G., Cittadini A., Sabatini D., Marciano-Mone C., Saccà L, Bellastella A. Body composition, bone metabolism and heart structure and function in Growth Hormone (GH) deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 1993, 177: 1671-1676.
9. Merola B., Cittadini A., Colao A., Longobardi S., Fazio S., Sabatini D., Saccà L., Lombardi G. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 1993, 777: 1658-1661.
10. Salomon F., Cuneo R.C., Hesp R., Sonksen P. The effect of treatment with recombinant human growth hormone on body composition and metabolism in adult with growth hormone deficiency. N. Engl. J. Med. 1989, 321: 1797-1803.
11. Duerr R.L., McKirnan M.D., Gim R.D., Clark R.G., Kien K.R., Ross J.Jr. Cardiovascular effects of Insulin-like Growth Factor I and growth hormone in chronic left ventricular failure in the rat. Circulation 1996, 93: 2188-2196.
12. Fazio S., Sabatini D., Capaldo B., Vigorito C., Giordano A., Guida R., Pardo F., Biondi B., Saccà L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 1996, 334: 809-814.
13. Osterziel K.J., Strohm O., Schuler J., Friedrich M., Manien D., Willenbrock R., Anker S.D., Poole-Wilson P.A., Ranke M.B., Dietz R. Randomized, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998, 57: 1233-1237.
14. Volterrani M., Desenzani P., Lorusso R., d'Aloia A., Manelli F., Giustina A. Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 1991, 359: 1067-1068.
15. Donath M.Y., Jenni R., Brunner H.P., Anrig M., Kohli S., Glatz Y., Froesch E.R. Cardiovascular and metabolic effects of Insulin-like Growth Factor-I at rest and during exercise in humans. J. Clin. Endocrinol. Metabl 1996, 81: 4089-4094.
16. Donath M.Y., Sutsch G., Yan X.W., Piva B., Brunner H.P., Glatz Y., Glatz Y., Zpaf J., Follath F., Froesch E.R., Kiowski W. Acute cardiovascular effects of Insulin-Like Growth Factor I in patients with chronic heart failure. J. Clin. Endocrinol. Metab. 1998, 83: 3177-3183.
17. Russel-Jones D.L., Bates A.T., Umpleby A.M., Hennessy T.R., Bowes S.B., Hopkins K.D., Jackson N., Kelly J., Shojaee-Moradie F., Jones R.H., Sonksen P.M. A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur. J. Clin. Invest. 1995, 25: 403-411.
18. Bowers C.Y., Veeraragavan K., Sethumadhavan K. Atypical growth hormone releasing peptides. In: Bercu B.B., Walker R.F. (Eds.), Growth hormone II, basic and clinical aspects. Springer-Verlag, New York, 1993, pp. 203-222.
19. Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone-releasing peptides. Eur. J. Endocrinol. 1997, 136: 445-460.
20. Smith R.G., Van der Ploeg L.X.T., Howard A.D., Feighner S.D., Chang K., Mickey G.J., Wyvratt M.J., Fisher M.H., Nargunt R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 1997, 18: 621-645.
21. Arvat E., Di Vito L., Maccagno B., Broglio F., Boghen M.F., Deghenghi R., Camanni F., Ghigo E. Effects of GHRP-2 and Hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol level in man. Comparison with the effects of GHRH, TRH, and hCRH. Peptides 1997, 18: 885-891.
22. Arvat E., Di Vito L., Lanfranco F., Broglio F., Giordano R., Benso A., Muccioli G., Deghenghi R., Ghigo E. Tyr-Ala-Hexarelin, a synthetic octapetide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. J. Endocrinol. Invest. 1999, 22: 91, in press.
23. Arvat E., Maccagno B., Ramunni J., Broglio F., Lanfranco F., Giordano R., Benso A., Deghenghi R., Ghigo E. Influence of galanin and serotonin on the endocrine response to Hexarelin, a peptidyl GH-secretagogue, In normal women. J. Endocrinol. Invest. 1998, 27: 673-679.
24. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C., Uamelin M., Ureniuk D.I., Palyme O.C., Anderson J., Paress P.S., Diaz C., Choun Liu K.K., Pong S.S., Cheung L.Y., Elbrecht A., Dashkeiviez M., Keavens R., Rishy M., Siringjhsinghji D.I.S., Dean D.C., Melillo D.G., Patchett A.A., Nergund R., Srillin P.R. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273: 974-977.
25. 125I]p-benzoyl-phenylalanine Hexarelin derivative. Endocrinology 1998, 739: 432-435.
26. Muccioli G., Ghe C., Ghigo M.C., Arvat E., Papotti M., Boghen M.F., Nillsson M., Deghenghi R., Ong H., Ghigo E. GHRP receptors in pituitary, central nervous system and peripheral human tissues. Proc XXVII National Congress of the Italian Society of Endocrinology, Sorrento, Italy, 1997. J. Endocrinol. Invest. 1997, 20 (Suppl. 4): 52 (Abs.).
27. Muccioli G., Ghè C., Papotti M, Boghen M.F., Nillson M., Deghenghi R., Ong H., Ghigo E. Tissue distribution of GHRP receptors in humans. Proc IV European Congress of Endocrinology, Sevilla, Spain, 9-13 May 1998. OR 15-7 (Abs.).
28. th 1998, P2-239 (Abstract).
29. Ong H., Bodart V., Mc Nicoll N., Lamontagne D., Bouchard J.F. Binding siteds for growth hormone-releasing peptide. GH and IGF-I Research 1998, 8: 137-143.
30. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinhji D.J.S., Smith R.G., Van der Ploeg L.H.T., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol. Brain Res. 1998, 48: 23-29.
31. De Gennaro Colonna V., Rossoni G., Bernareggi M., Muller E.E., Berti F. Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: protection by hexarelin. Eur. J. Pharmacol. 1997, 34: 201-207.
32. Rossoni G., De Gennaro Colonna V., Bernareggi M., Polvani G.L., Muller E.E., Berti F. Protectant activity of Hexarelin or growth hormone against post-ischemic ventricular dysfunction in hearts from aged rats. J. Cardiovas. Pharmacol. 1998, in press.
33. Berti F., Muller E.E., De Gennaro Colonna V., Rossoni G. Hexarelin exibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats. GH and IGF-I Research 1998, 8: 149-155.
34. Isgaard J., Tivesten A., Bollano E., Kujacic V., Caidahl K., Sun X.Y., Hedner T., Hjalmarson A., Bengtsson B.A. The growth hormone secretagogue Hexarelin improves cardiac function in rats after experimental myocardial infarction. Proc. IV European Congress of Endocrinology, Sevilla, Spain, 9-13 May 1998; OR 3-7 (Abs.).
35. Links J.M., Becker L.C., Shindledecker J.G., Guzman P., Burow R.D., Nickoloff E.L., Alderson P.O., Wagner H.N. Measurement of absolute left ventricular volume from gated blood pool studies. Circulation 1982, 65: 82-91.
36. De Gennaro Colonna V., Rossoni G., Bonacci D., Ciceri S., Cattaneo L., Muller E.E., Berti F. Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency. Eur. J. Pharmacol. 1996, 14: 333-338.
37. Muller E.E., Nistico G. Neurotransmitter regulation of the anterior pituitary. In: Muller E.E., Nisticò G. (Eds.), Brain messengers and the pituitary. Academic Press, San Diego, 1989, pp. 404-537.
38. Heldwein K.A., Redick D.L., Rittenberg M.B., Claycomb W.C., Stenzel-Poore M.P. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-I cells. Endocrinology 1996, 737: 3631-3639.